Angiogenesis in breast cancer. Regulation, prognostic aspects, and implications for novel treatment strategies.
Horak
E R
ER
Nuffield Department of Pathology and Bacteriology, University of Oxford, John Radcliffe Hospital, United Kingdom.
Harris
A L
AL
Stuart
N
N
Bicknell
R
R
D014408:Biomarkers, Tumor / Q000032:analysis; D001943:Breast Neoplasms / Q000098:blood supply* / Q000473:pathology / Q000601:surgery / Q000628:therapy*; D004730:Endothelium, Vascular / Q000187:drug effects / Q000473:pathology; D066246:ErbB Receptors / Q000032:analysis; D005260:Female; D006133:Growth Substances / Q000494:pharmacology / Q000502:physiology; D006801:Humans; D008207:Lymphatic Metastasis; D009361:Neoplasm Invasiveness; D009389:Neovascularization, Pathologic / Q000473:pathology*; D011379:Prognosis
D014408:Biomarkers, Tumor; D006133:Growth Substances; D066246:ErbB Receptors